BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30060032)

  • 21. Comparison of overall survival between antiviral-induced viral suppression and inactive phase chronic hepatitis B patients.
    Cho YY; Lee JH; Chang Y; Nam JY; Cho H; Lee DH; Cho EJ; Lee DH; Yu SJ; Lee JM; Kim YJ; Yoon JH
    J Viral Hepat; 2018 Oct; 25(10):1161-1171. PubMed ID: 29741286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic Hepatitis B Increases Liver-Related Mortality of Patients With Acute Hepatitis E: A Territorywide Cohort Study From 2000 to 2016.
    Lai JC; Wong GL; Yip TC; Tse YK; Lam KL; Lui GC; Chan HL; Wong VW
    Clin Infect Dis; 2018 Sep; 67(8):1278-1284. PubMed ID: 30265321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and C.
    Golabi P; Paik JM; Eberly K; de Avila L; Alqahtani SA; Younossi ZM
    Ann Hepatol; 2022; 27(1):100556. PubMed ID: 34800721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic hepatitis B infection is not associated with increased risk of vascular mortality while having an association with metabolic syndrome.
    Katoonizadeh A; Ghoroghi S; Sharafkhah M; Khoshnia M; Mirzaei S; Shayanrad A; Poustchi H; Malekzadeh R
    J Med Virol; 2016 Jul; 88(7):1230-7. PubMed ID: 26742819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased risk of cirrhosis and its decompensation in chronic hepatitis B patients with newly diagnosed diabetes: a nationwide cohort study.
    Huang YW; Wang TC; Lin SC; Chang HY; Chen DS; Hu JT; Yang SS; Kao JH
    Clin Infect Dis; 2013 Dec; 57(12):1695-702. PubMed ID: 24051864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Healthcare resource utilization and costs by disease severity in an insured national sample of US patients with chronic hepatitis B.
    Nguyen MH; Burak Ozbay A; Liou I; Meyer N; Gordon SC; Dusheiko G; Lim JK
    J Hepatol; 2019 Jan; 70(1):24-32. PubMed ID: 30287341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distribution of disease phase, treatment prescription and severe liver disease among 1598 patients with chronic hepatitis B in the Chronic Hepatitis Cohort Study, 2006-2013.
    Spradling PR; Xing J; Rupp LB; Moorman AC; Gordon SC; Teshale ET; Lu M; Boscarino JA; Schmidt MA; Trinacty CM; Holmberg SD;
    Aliment Pharmacol Ther; 2016 Nov; 44(10):1080-1089. PubMed ID: 27640985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonalcoholic Steatohepatitis Is Associated With Liver-Related Outcomes and All-Cause Mortality in Chronic Hepatitis B.
    Choi HSJ; Brouwer WP; Zanjir WMR; de Man RA; Feld JJ; Hansen BE; Janssen HLA; Patel K
    Hepatology; 2020 Feb; 71(2):539-548. PubMed ID: 31309589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population health impact and cost-effectiveness of monitoring inactive chronic hepatitis B and treating eligible patients in Shanghai, China.
    Toy M; Salomon JA; Jiang H; Gui H; Wang H; Wang J; Richardus JH; Xie Q
    Hepatology; 2014 Jul; 60(1):46-55. PubMed ID: 24990105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term lamivudine for chronic hepatitis B and cirrhosis: A real-life cohort study.
    Su MH; Lu AL; Li SH; Zhong SH; Wang BJ; Wu XL; Mo YY; Liang P; Liu ZH; Xie R; He LX; Fu WD; Jiang JN
    World J Gastroenterol; 2015 Dec; 21(46):13087-94. PubMed ID: 26673249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of mortality in patients under treatment for chronic hepatitis B in Ethiopia: a prospective cohort study.
    Desalegn H; Aberra H; Berhe N; Medhin G; Mekasha B; Gundersen SG; Johannessen A
    BMC Gastroenterol; 2019 May; 19(1):74. PubMed ID: 31092203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative risk of liver-related mortality from chronic hepatitis B versus chronic hepatitis C virus infection.
    Falade-Nwulia O; Seaberg EC; Rinaldo CR; Badri S; Witt M; Thio CL
    Clin Infect Dis; 2012 Aug; 55(4):507-13. PubMed ID: 22523269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural History of Chronic Hepatitis B Virus Infection in Ahvaz City, Iran.
    Makvandi M; Soleimani Jelodar R; Samarbafzadeh A; Neisi N; Sharifi Z; Gholampour A; Masjedizadeh A; Shayesteh A
    Asian Pac J Cancer Prev; 2018 Aug; 19(8):2125-2129. PubMed ID: 30139211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regional Differences in Mortality Rates and Characteristics of Decedents With Hepatitis B Listed as a Cause of Death, United States, 2000-2019.
    Ly KN; Yin S; Spradling PR
    JAMA Netw Open; 2022 Jun; 5(6):e2219170. PubMed ID: 35763293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.
    Johnson NB; Hayes LD; Brown K; Hoo EC; Ethier KA;
    MMWR Suppl; 2014 Oct; 63(4):3-27. PubMed ID: 25356673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High risk of hepatocellular carcinoma and death in patients with immune-tolerant-phase chronic hepatitis B.
    Kim GA; Lim YS; Han S; Choi J; Shim JH; Kim KM; Lee HC; Lee YS
    Gut; 2018 May; 67(5):945-952. PubMed ID: 29055908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of hepatitis E virus seroprevalence between HBsAg-positive population and healthy controls in Shandong province, China.
    Zhang L; Jiang Z; Lv J; Liu J; Yan B; Feng Y; Li L; Zhang G; Wang F; Xu A
    BMC Infect Dis; 2018 Feb; 18(1):75. PubMed ID: 29433428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long term outcome of antiviral therapy in patients with hepatitis B associated decompensated cirrhosis.
    Ju YC; Jun DW; Choi J; Saeed WK; Lee HY; Oh HW
    World J Gastroenterol; 2018 Oct; 24(40):4606-4614. PubMed ID: 30386110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progression to cirrhosis, hepatocellular carcinoma and liver-related mortality in chronic hepatitis B patients in Italy.
    Ieluzzi D; Covolo L; Donato F; Fattovich G
    Dig Liver Dis; 2014 May; 46(5):427-32. PubMed ID: 24548819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B.
    Wong GL; Chan HL; Wong CK; Leung C; Chan CY; Ho PP; Chung VC; Chan ZC; Tse YK; Chim AM; Lau TK; Wong VW
    J Hepatol; 2014 Feb; 60(2):339-45. PubMed ID: 24128413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.